1 Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
2 Department of Psychology, Swansea University, UK.
J Psychopharmacol. 2018 Oct;32(10):1133-1140. doi: 10.1177/0269881118791737. Epub 2018 Sep 5.
A significant proportion of depressed patients fail to respond to treatment with antidepressant drugs. Such patients might nonetheless respond to deep brain stimulation of the prefrontal cortex. Deep brain stimulation has also been shown to normalize behaviour in the chronic mild stress (CMS) model of depression. However, these studies have involved animals that are in general treatment responsive. Thus, this is not the ideal situation in which to investigate how deep brain stimulation is effective where antidepressant drugs are not.
Here, we studied the behavioural effects of deep brain stimulation in treatment-resistant animals.
Wistar rats were exposed to chronic mild stress and concurrent treatment with saline or one of three antidepressant drugs, imipramine, citalopram and venlafaxine. Individuals were selected from the CMS-exposed drug-treated groups that had failed to increase their sucrose intake by week 5 of drug treatment. All animals were then implanted with deep brain stimulation electrodes in the ventro-medial prefrontal cortex, and tested for sucrose intake and in the elevated plus maze and novel object recognition test, following 2 × 2 h of deep brain stimulation.
The selected drug-treated animals were found to be antidepressant-resistant in all three tests. With a single exception (sucrose intake in imipramine-treated animals), deep brain stimulation reversed the anhedonic, anxiogenic and dyscognitive effects of CMS in all four conditions, with no significant differences between saline- and drug-treated animals.
These data provide a proof of principle that deep brain stimulation of the prefrontal cortex can be effective in a rat model of resistance to chronic antidepressant treatment, replicating the clinical effect of deep brain stimulation in treatment-resistant depression.
相当一部分抑郁症患者对抗抑郁药物治疗没有反应。然而,这些患者可能会对前额叶皮层的深部脑刺激产生反应。深部脑刺激也已被证明可以使慢性轻度应激(CMS)抑郁模型中的行为正常化。然而,这些研究涉及的动物通常对治疗有反应。因此,这不是研究深部脑刺激在抗抑郁药物无效的情况下如何有效的理想情况。
本研究旨在研究治疗抵抗动物中深部脑刺激的行为效应。
Wistar 大鼠暴露于慢性轻度应激和同时给予生理盐水或三种抗抑郁药(丙咪嗪、西酞普兰和文拉法辛)治疗。从 CMS 暴露的药物治疗组中选择那些在药物治疗第 5 周未能增加其蔗糖摄入量的个体。所有动物随后在前额叶腹内侧深部脑刺激电极,并在深部脑刺激后 2×2 小时进行蔗糖摄入量测试和高架十字迷宫和新物体识别测试。
所选的药物治疗动物在所有三种测试中均被发现为抗抑郁药抵抗。除了一个例外(丙咪嗪治疗动物的蔗糖摄入量),深部脑刺激逆转了 CMS 在所有四种情况下的快感缺失、焦虑和认知障碍效应,生理盐水和药物治疗动物之间没有显著差异。
这些数据提供了一个原理证明,即前额叶皮层的深部脑刺激可以在慢性抗抑郁治疗抵抗的大鼠模型中有效,复制了深部脑刺激在治疗抵抗性抑郁症中的临床效果。